Literature DB >> 16687141

Hero versus antihero: the multiple roles of alpha-synuclein in neurodegeneration.

Mark R Cookson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16687141     DOI： 10.1016/j.expneurol.2006.03.011

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  10 in total

1.  Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.

Authors:  Timothy J Collier; Kinshuk R Srivastava; Craig Justman; Tom Grammatopoulous; Birgit Hutter-Paier; Manuela Prokesch; Daniel Havas; Jean-Christophe Rochet; Fang Liu; Kevin Jock; Patrícia de Oliveira; Georgia L Stirtz; Ulf Dettmer; Caryl E Sortwell; Mel B Feany; Peter Lansbury; Lisa Lapidus; Katrina L Paumier
Journal:  Neurobiol Dis       Date:  2017-07-12       Impact factor: 5.996

Review 2.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

Review 3.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

Review 4.  The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review.

Authors:  Mariangela Spano; Maria Signorelli; Roberta Vitaliani; Eugenio Aguglia; Bruno Giometto
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 5.  Cell systems and the toxic mechanism(s) of alpha-synuclein.

Authors:  Mark R Cookson; Marcel van der Brug
Journal:  Exp Neurol       Date:  2007-06-04       Impact factor: 5.330

6.  Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.

Authors:  Kavita Prasad; Thomas G Beach; John Hedreen; Eric K Richfield
Journal:  Brain Pathol       Date:  2012-05-23       Impact factor: 6.508

7.  Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates.

Authors:  Timothy J Collier; D Eugene Redmond; Kathy Steece-Collier; Jack W Lipton; Fredric P Manfredsson
Journal:  Front Neurosci       Date:  2016-01-29       Impact factor: 4.677

Review 8.  The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Authors:  Matthew J Benskey; Ruth G Perez; Fredric P Manfredsson
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

9.  Conformational equilibria in monomeric alpha-synuclein at the single-molecule level.

Authors:  Massimo Sandal; Francesco Valle; Isabella Tessari; Stefano Mammi; Elisabetta Bergantino; Francesco Musiani; Marco Brucale; Luigi Bubacco; Bruno Samorì
Journal:  PLoS Biol       Date:  2008-01       Impact factor: 8.029

Review 10.  Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?

Authors:  Nicholas M Kanaan; Fredric P Manfredsson
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.